MENU
BBH
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

BBH stock forecast, quote, news & analysis

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® U... Show more

Category: #Health
BBH
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for BBH with price predictions
Sep 24, 2026

BBH's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for BBH turned positive on September 24, 2026. Looking at past instances where BBH's MACD turned positive, the stock continued to rise in 47 of 53 cases over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on BBH as a result. In 79 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.

Following a +3.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where BBH advanced for three days, in 246 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

BBH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 211 of 242 cases where BBH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 87%.

Bearish Trend Analysis

The 10-day RSI Indicator for BBH moved out of overbought territory on August 28, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 22 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BBH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Biogen (NASDAQ:BIIB), Incyte Corp (NASDAQ:INCY).

Industry description

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® U.S. Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Market Cap

The average market capitalization across the VanEck Biotech ETF (BBH) ETF is 45.75B. The market cap for tickers in the group ranges from 9.03B to 219.55B. AMGN holds the highest valuation in this group at 219.55B. The lowest valued company is QGEN at 9.03B.

High and low price notable news

The average weekly price growth across all stocks in the VanEck Biotech ETF (BBH) ETF was 3%. For the same ETF, the average monthly price growth was 0%, and the average quarterly price growth was 35%. MRNA experienced the highest price growth at 23%, while NBIX experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the VanEck Biotech ETF (BBH) ETF was -6%. For the same stocks of the ETF, the average monthly volume growth was -29% and the average quarterly volume growth was -19%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 47
Price Growth Rating: 40
SMR Rating: 66
Profit Risk Rating: 71
Seasonality Score: -22 (-100 ... +100)
View a ticker or compare two or three
BBH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Category
Health
Address
335 Madison Ave.19th FloorNew York
Phone
888-658-8287
Web
www.marketvectorsetfs.com
BBH's MACD Histogram just turned positive